Next Article in Journal
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
Next Article in Special Issue
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
Previous Article in Journal
Larvicidal and Enzymatic Inhibition Effects of Annona Muricata Seed Extract and Main Constituent Annonacin against Aedes Aegypti and Aedes Albopictus (Diptera: Culicidae)
Previous Article in Special Issue
VitalSign6: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression
 
 
Review

Article Versions Notes

Pharmaceuticals 2019, 12(3), 113; https://doi.org/10.3390/ph12030113
Action Date Notes Link
article xml file uploaded 29 July 2019 10:10 CEST Original file -
article xml uploaded. 29 July 2019 10:10 CEST Update https://www.mdpi.com/1424-8247/12/3/113/xml
article pdf uploaded. 29 July 2019 10:10 CEST Version of Record https://www.mdpi.com/1424-8247/12/3/113/pdf
article html file updated 29 July 2019 10:11 CEST Original file -
article html file updated 26 September 2019 17:30 CEST Update -
article html file updated 13 February 2020 05:44 CET Update -
article html file updated 20 July 2022 06:12 CEST Update https://www.mdpi.com/1424-8247/12/3/113/html
Back to TopTop